Molecular Response Assessment with Immune Adaptive PERCIST in Lung Cancer Patients Treated with Nivolumab: Is It Better Than iRECIST?

Por Manoj Gupta, Partha S. Choudhury, Parveen Jain, Manish Sharma, Venkata P. B. Koyyala, Sumit Goyal, Chaturbhuj Agarwal, Ankush Jajodia, Sunil Pasricha, Anurag Sharma, Ullas Batra
Publicado em 2022-03-01